| __timestamp | Arrowhead Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 91813000 |
| Thursday, January 1, 2015 | 382000 | 178203000 |
| Friday, January 1, 2016 | 158333 | 216080000 |
| Sunday, January 1, 2017 | 31407709 | 241203000 |
| Monday, January 1, 2018 | 16142321 | 214109000 |
| Tuesday, January 1, 2019 | 168795577 | 204890000 |
| Wednesday, January 1, 2020 | 87992066 | 227976000 |
| Friday, January 1, 2021 | 138287000 | 356128000 |
| Saturday, January 1, 2022 | 243231000 | 426409000 |
| Sunday, January 1, 2023 | 240735000 | 837999000 |
| Monday, January 1, 2024 | 3551000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. This article delves into the annual revenue trends of two prominent players: HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc. Over the past decade, HUTCHMED has demonstrated a robust growth trajectory, with its revenue surging from approximately $92 million in 2014 to an impressive $838 million by 2023. This represents a nearly 810% increase, underscoring its expanding influence in the pharmaceutical sector.
Conversely, Arrowhead Pharmaceuticals has experienced a more volatile revenue pattern. Starting at a modest $175,000 in 2014, it peaked at $243 million in 2022, before a significant drop in 2024. This fluctuation highlights the challenges and unpredictability inherent in the biotech industry. As these companies continue to innovate, their financial journeys offer valuable insights into the sector's evolving landscape.
Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc. Performance Compared
Comparing Revenue Performance: Bristol-Myers Squibb Company or Arrowhead Pharmaceuticals, Inc.?
Gilead Sciences, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Dr. Reddy's Laboratories Limited and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Who Generates More Revenue? PTC Therapeutics, Inc. or HUTCHMED (China) Limited
Revenue Insights: HUTCHMED (China) Limited and ImmunityBio, Inc. Performance Compared
HUTCHMED (China) Limited and Geron Corporation: A Comprehensive Revenue Analysis
Revenue Insights: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Performance Compared
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics